FibroBiologics Inc [FBLG] stock prices are up 3.64% to $2.56 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The FBLG shares have gain 14.29% over the last week, with a monthly amount drifted -6.91%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
FibroBiologics Inc [NASDAQ: FBLG] stock has seen the most recent analyst activity on October 30, 2024, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $12. Previously, Maxim Group started tracking the stock with Buy rating on September 24, 2024, and set its price target to $12.
The stock price of FibroBiologics Inc [FBLG] has been fluctuating between $1.08 and $55.00 over the past year. Currently, Wall Street analysts expect the stock to reach $9 within the next 12 months. FibroBiologics Inc [NASDAQ: FBLG] shares were valued at $2.56 at the most recent close of the market. An investor can expect a potential return of 251.56% based on the average FBLG price forecast.
Analyzing the FBLG fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.7, Equity is 31.47 and Total Capital is -3.3. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.45 points at the first support level, and at 2.34 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.68, and for the 2nd resistance point, it is at 2.80.
Ratios To Look Out For
It’s worth pointing out that FibroBiologics Inc [NASDAQ:FBLG]’s Current Ratio is 1.23. In addition, the Quick Ratio stands at 1.23 and the Cash Ratio stands at 1.17.
Transactions by insiders
Recent insider trading involved O’HEERON PETE, Chief Executive Officer, that happened on Aug 12 ’24 when 8500.0 shares were purchased. Chief Scientific Officer, Khoja Hamid completed a deal on Aug 12 ’24 to buy 10000.0 shares.
